David Marin, MD

Trials

Studies that name David Marin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:31 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT05092451 · Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

  M.D. Anderson Cancer Center · recruiting · B-Cell Lymphoma, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) · principal investigator
• Early Ph1
  NCT04742595 · Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

  M.D. Anderson Cancer Center · completed · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed · principal investigator
• Ph1/Ph2
  NCT03600896 · Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation

  M.D. Anderson Cancer Center · withdrawn · Umbilical Cord Blood Transplant · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Hematopoietic Progenitor Cells- Cord Blood
  R01CA061508 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Katy Rezvani, Elizabeth J Shpall · fiscal years 1993 to 2020
  Named on NCT03600896